AU Patent

AU636066B2 — Thienoimidazole derivatives, their production and use

Assigned to Takeda Pharmaceutical Co Ltd · Expires 1993-04-08 · 33y expired

What this patent protects

Benzimidazole derivatives of the formula (I): <CHEM> wherein the ring A is a thiophene ring which may optionally contain substitution in addition to the R<3> group; R<1> is hydrogen or optionally substituted hydrocarbon residue which may be bonded through a hete…

USPTO Abstract

Benzimidazole derivatives of the formula (I): <CHEM> wherein the ring A is a thiophene ring which may optionally contain substitution in addition to the R<3> group; R<1> is hydrogen or optionally substituted hydrocarbon residue which may be bonded through a hetero atom; R<2> and R<3> are independently a group capable of forming an anion or a group convertible thereinto; X is a direct bond or a spacer having an atomic length of two or less between the phenylene group and the phenyl group; and n is an integer of 1 or 2; or a salt thereof, have potent angiotensin II antagonistic activity and antihypertensive activity, thus being useful as therapeutic agents for treating circulatory system diseases such as hypertensive diseases, heart diseases (e.g. hypercardia, heart failure, cardiac infarction, etc.), strokes, cerebral apoplexy, nephritis, etc.

Drugs covered by this patent

Patent Metadata

Patent number
AU636066B2
Jurisdiction
AU
Classification
Expires
1993-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.